Skip to content

Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation

Prospective, Multicenter,Randomized Clinical Investigation of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation to Treat High Myopia: A Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03059043
Enrollment
60
Registered
2017-02-23
Start date
2018-11-16
Completion date
2028-06-22
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Phakic Intraocular Lenses, viscoelastic

Brief summary

This study evaluates the safety and efficacy of a viscoelastic-free method for Implantable Collamer Lens(ICL) implantation to treat high myopia. The subjects undergo randomization of ICL implantation using the viscoelastic-free method on one eye and undergoing standard method on the other one. The post-operative data are collected for analysis.

Detailed description

Implantable Collamer Lens(ICL) implantation has been proved to be an effective refractive option for surgical correction of high myopia. Currently, standard method utilizing the viscoelastic agent to fill and maintain the anterior chamber during the implantation, this requires an additional step to remove the viscoelastic agent at the end of the surgery and may cause the intraocular pressure spike in the early post-operative phase due to the incomplete removal of the viscoelastics. The new method is viscoelastic-free, which can be achieved by using balanced salt solution irrigation during the implantation. This study is a prospective, randomized, paired-eye study to compare the safety and efficacy of the viscoelastic-free method with the standard method. Subjects enrolled in the study will be randomized to receive viscoelastic-free method on one eye and undergo standard method on the other one.The clinical outcomes of two groups will be assessed at several follow-ups: 2 hours, 1 day, 1 week, 1 month, 3 months and 6 months post-operatively.

Interventions

DEVICEviscoelastic-free implantation system

Viscoelastic-free implantation system use balanced salt solution irrigation during the implantation

DEVICEstandard viscoelastic-assisted Implantation system

This method utilize the viscoelastic agent to fill and maintain the anterior chamber during the implantation

Sponsors

Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Documented stable refraction for at least 1 year(within 0.5D) * Best spectacle-corrected visual acuity (BCVA) of 20/40 or better * Clear central cornea * -0.5D to -18.0D of myopic refractive error * Normal anterior chamber depth at least 2.8 mm to endothelium * Endothelial cell density (ECD) more than 2000 cell/mm2 * Pupil diameter smaller than 7.0 mm under mesopic condition * Discontinued 3 weeks for hard contact lens and 1 week for soft contact lens wear

Exclusion criteria

* Preexisting ocular diseases or conditions other than myopia, evidence of progressive or acute ocular disease * Evidence of connective tissue disease or other systemic diseases that may confound the results of the study; * Narrow angle of anterior chamber * Pregnant, lactating, or planning to become pregnant during the course of the trial

Design outcomes

Primary

MeasureTime frameDescription
Early Post-operative Intraocular Pressure2 hours after surgeryIntraocular Pressure measured by non-contact tonometers

Secondary

MeasureTime frameDescription
Corrected Visual Acuity (UCVA) at Distancebaseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgerySubjective refraction
Uncorrected Visual Acuity (UCVA) at Distancebaseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgeryMeasure by visual acuity chart
Endothelial Cell Densitybaseline, 1 month, 3 months and 6 months after surgeryMeasure by Specular Microscope
Vault measured by anterior segment OCT2 hours, 1 day, 1 week, 1 month, 3 months and 6 months after surgeryVault measured by anterior segment OCT
Intraocular Pressurebaseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgeryIntraocular Pressure measured by non-contact tonometers
Refractive error (by Phoropter)baseline, 1 day, 1 week, 1 month, 3 months and 6 months after surgerysubjective refraction by Phoropter
Anterior chamber reaction (by a laser flare meter)baseline, 2 hours, 1 day, 1 week after surgeryanterior chamber flare value was examined by a laser flare meter
Duration of operationat the time of the surgeryTime from the first incision is made to the end of the surgery
Complications of ICL implantationup to 6 months after surgeryLens opacities, Cataract surgery, Pupillary block, Ocular hypertension or glaucoma

Countries

China

Contacts

CONTACTAYong Yu, MD. PhD.
yaybetter@hotmail.com+86-0577-88068880
CONTACTAnpeng Pan, MD.OD.
pananpeng@126.com
PRINCIPAL_INVESTIGATORAYong Yu, MD. PhD.

Wenzhou Medical University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026